International Clinical Trial: REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07213778) titled 'REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants' on Oct. 3.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Regeneron Pharmaceuticals

Condition: Symptomatic Venous Thromboembolism (VTE)

Intervention: Drug: REGN7508 Drug: Acetylsalicylic Acid (ASA)

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: December 5, 2025

Target S...